stella
beta
Post-market Surveillance Study of the BD® WavelinQ™ EndoAVF System — Stella
Home
/
Kidney Disease, End-Stage
/
Post-market Surveillance Study of the BD® WavelinQ™ EndoAVF System
View on ClinicalTrials.gov
Recruiting
Back to Kidney Disease, End-Stage trials
Post-market Surveillance Study of the BD® WavelinQ™ EndoAVF System
Not a traditional drug trial — this study doesn't follow the standard phase structure.
Trial locations
(17 sites)
United States
California Institute of Renal Research, La Jolla, California
San Francisco Vein & Vascular, San Francisco, California
First Coast Cardiovascular Institute Pa, Jacksonville, Florida
Radiology and Imaging Specialists, Lakeland, Florida
Vascular and Spine Institute Inc, Miami, Florida
Kidney Care and Transplant Services of NE, Springfield, Massachusetts
Kidney Care & Transplant Services of New England, West Springfield, Massachusetts
UMass Chan School of Medicine, Worcester, Massachusetts
Albany Medical Center, Albany, New York
NC Nephrology, Raleigh, North Carolina
ProMedica Toledo Hospital, Toledo, Ohio
Butler Memorial Hospital, Butler, Pennsylvania
Vascular Institute of Chattanooga, Chattanooga, Tennessee
Bluff City Vascular, Memphis, Tennessee
University of Texas Southwestern Medical Center, Dallas, Texas
Houston Methodist, Houston, Texas
Australia
Southern Adelaide Local Health Network, Bedford Park, South Australia